Investing.com - GlaxoSmithKline reported on Wednesday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
GlaxoSmithKline announced earnings per share of £0.281 on revenue of £8.09B. Analysts polled by Investing.com anticipated EPS of £0.1982 on revenue of £7.6B.
GlaxoSmithKline shares are up 12% from the beginning of the year and are trading at £1,401.80 , down-from-52-week-high.They are under-performing the OMX Helsinki 25 which is up 22.26% from the start of the year.
GlaxoSmithKline shares gained 0.19% in intra-day trade the report.
GlaxoSmithKline follows other major Healthcare sector earnings this month
GlaxoSmithKline's report follows an earnings beat by ReNeuron on July 8, who reported EPS of £-0.09 on revenue of £216.0K, compared to forecasts EPS of £-12.70 on revenue of £1.00M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar